These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 23744143)

  • 1. It takes nerves to recover from chemotherapy.
    Levesque JP; Winkler IG
    Nat Med; 2013 Jun; 19(6):669-71. PubMed ID: 23744143
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemotherapy-induced bone marrow nerve injury impairs hematopoietic regeneration.
    Lucas D; Scheiermann C; Chow A; Kunisaki Y; Bruns I; Barrick C; Tessarollo L; Frenette PS
    Nat Med; 2013 Jun; 19(6):695-703. PubMed ID: 23644514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sympathetic nerves stimulate bone marrow function after chemotherapy.
    Cancer Discov; 2013 Jul; 3(7):OF15. PubMed ID: 23847358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes in the effect of some antineoplastic agents after erythropoietic stimulation].
    Bogliolo G; Saviane A; Massa G; Ghio R; Bianchi G; Pannacciulli I
    Tumori; 1976; 62(4):445-54. PubMed ID: 1020051
    [No Abstract]   [Full Text] [Related]  

  • 5. [The toxic action of antineoplastic chemotherapeutic agents evaluated by study of hemopoietic stem cells].
    Pannacciulli I; Ghio R; Bianchi G; Bogliolo G; Saviane A; Massa G
    Minerva Med; 1978 Dec; 69(61):4257-65. PubMed ID: 366466
    [No Abstract]   [Full Text] [Related]  

  • 6. Residual marrow injury following cytotoxic drugs.
    Trainor KJ; Seshadri RS; Morley AA
    Leuk Res; 1979; 3(4):205-10. PubMed ID: 533991
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasminogen activator inhibitor type-1 is a negative regulator of hematopoietic regeneration in the adipocyte-rich bone marrow microenvironment.
    Harada K; Yahata T; Onizuka M; Ibrahim AA; Kikkawa E; Miyata T; Ando K
    Biochem Biophys Res Commun; 2021 Jun; 557():180-186. PubMed ID: 33866038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocytic recovery after experimental suppression of haemopoiesis in the rat.
    Berger J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(5):599-603. PubMed ID: 6083933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of hyperthermia at 40.5 degrees C and cytostatic drugs on human bone marrow progenitor cells.
    Neumann HA; Engelhardt R
    Recent Results Cancer Res; 1988; 109():57-63. PubMed ID: 3175299
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of granulocyte colony-stimulating factor on kinetics of hemopoietic precursors in regenerating bone marrow.
    Goldberg ED; Dygai AM; Zhdanov VV; Guryantseva LA; Udut EV; Popova NO; Simanina EV; Khrichkova TY
    Bull Exp Biol Med; 2005 Jan; 139(1):154-7. PubMed ID: 16142300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stem cell defects after cytoreductive therapy in man.
    Schreml W; Lohrmann HP; Anger B
    Exp Hematol; 1985; 13 Suppl 16():31-42. PubMed ID: 2985415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stem cell maneuvers target bone marrow toxicity.
    Randal J
    J Natl Cancer Inst; 1999 Sep; 91(18):1530-2. PubMed ID: 10491422
    [No Abstract]   [Full Text] [Related]  

  • 13. [The action of cyclo-specific and non-cyclo-specific antineoplastic agents on hematopoietic CFU in mice after bloodletting].
    Saviane A; Massa G; Bogliolo G; Pannacciulli I
    Boll Soc Ital Biol Sper; 1976 Mar; 52(6):465-8. PubMed ID: 949426
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term bone marrow damage in experimental systems and in patients after radiation or chemotherapy.
    Testa NG; Hendry JH; Molineux G
    Anticancer Res; 1985; 5(1):101-10. PubMed ID: 3888044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of the effects of alkylating agents, antimetabolites and antineoplastic agents of other types on hemopoietic CFU in mice].
    Massa G; Saviane A; Bogliolo G; Pannacciulli I
    Boll Soc Ital Biol Sper; 1976 Mar; 52(6):460-4. PubMed ID: 949425
    [No Abstract]   [Full Text] [Related]  

  • 16. Drugs and the bone marrow.
    Treleaven J; Barrett J
    Br J Hosp Med; 1990 Oct; 44(4):245-50. PubMed ID: 2249099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapeutic sensitivity of normal and leukemic hematopoietic progenitor cells to N-[4-(9-acridinylamino)-3-methoxyphenyl]-methanesulfonamide, a new anticancer agent.
    Spiro TE; Socquet M; Delforge A; Stryckmans P
    J Natl Cancer Inst; 1981 Apr; 66(4):615-8. PubMed ID: 6939909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxic effects of benzene and benzene metabolites on granulopoietic stem cells and bone marrow cellularity in mice.
    Tunek A; Olofsson T; Berlin M
    Toxicol Appl Pharmacol; 1981 Jun; 59(1):149-56. PubMed ID: 7256752
    [No Abstract]   [Full Text] [Related]  

  • 19. Screening of cytotoxic drugs for residual bone marrow damage.
    Trainor KJ; Morley AA
    J Natl Cancer Inst; 1976 Dec; 57(6):1237-9. PubMed ID: 1003558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of the hemopoiesis-inducing microenvironment in the mechanisms of the regeneration of hemopoiesis after cytostatic exposure].
    Dygaĭ AM; Zhadanov VV; Bogdashin IV; Gol'dberg VE
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1992; (9):109-16. PubMed ID: 1302526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.